{"id":52046,"date":"2022-12-15T18:03:08","date_gmt":"2022-12-15T17:03:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/"},"modified":"2022-12-15T18:03:08","modified_gmt":"2022-12-15T17:03:08","slug":"global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/","title":{"rendered":"Global Synthetic Bone Graft Substitutes Pipeline Report 2022: Featuring BioGend Therapeutics, Biomatlante, Biorez, BonAlive Biomaterials and Bone Solutions Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5642711\/synthetic-bone-graft-substitutes-pipeline-report?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=75r28b&amp;utm_campaign=1790600+-+Global+Synthetic+Bone+Graft+Substitutes+Pipeline+Report+2022%3A+Featuring+BioGend+Therapeutics%2C+Biomatlante%2C+Biorez%2C+BonAlive+Biomaterials+and+Bone+Solutions+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Synthetic Bone Graft Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221215005758\/en\/1666510\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221215005758\/en\/1666510\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report provides comprehensive information about the Synthetic Bone Graft Substitutes pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.\n<\/p>\n<p>\nSynthetic bone graft substitutes are used as substitutes to autograft and allograft bone.\n<\/p>\n<p>\n<strong>Scope<\/strong>\n<\/p>\n<ul>\n<li>\nExtensive coverage of the Synthetic Bone Graft Substitutes under development\n<\/li>\n<li>\nThe report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities\n<\/li>\n<li>\nThe report reviews the major players involved in the development of Synthetic Bone Graft Substitutes and list all their pipeline projects\n<\/li>\n<li>\nThe coverage of pipeline products based on various stages of development ranging from Early Development to Approved \/ Issued stage\n<\/li>\n<li>\nThe report provides key clinical trial data of ongoing trials specific to pipeline products\n<\/li>\n<li>\nRecent developments in the segment \/ industry\n<\/li>\n<\/ul>\n<p>\n<strong>Reasons to Buy<\/strong>\n<\/p>\n<p>\nThe report enables you to:\n<\/p>\n<ul>\n<li>\nFormulate significant competitor information, analysis, and insights to improve R&amp;D strategies\n<\/li>\n<li>\nIdentify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage\n<\/li>\n<li>\nIdentify and understand important and diverse types of Synthetic Bone Graft Substitutes under development\n<\/li>\n<li>\nDevelop market-entry and market expansion strategies\n<\/li>\n<li>\nPlan mergers and acquisitions effectively by identifying major players with the most promising pipeline\n<\/li>\n<li>\nIn-depth analysis of the product&#8217;s current stage of development, territory and estimated launch date\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Table of Contents<\/strong>\n<\/p>\n<p>\n<strong>2 Introduction<\/strong>\n<\/p>\n<p>\n<strong>3 Products under Development<\/strong>\n<\/p>\n<p>\n3.1 Synthetic Bone Graft Substitutes &#8211; Pipeline Products by Stage of Development\n<\/p>\n<p>\n3.2 Synthetic Bone Graft Substitutes &#8211; Pipeline Products by Territory\n<\/p>\n<p>\n3.3 Synthetic Bone Graft Substitutes &#8211; Pipeline Products by Regulatory Path\n<\/p>\n<p>\n3.4 Synthetic Bone Graft Substitutes &#8211; Pipeline Products by Estimated Approval Date\n<\/p>\n<p>\n3.5 Synthetic Bone Graft Substitutes &#8211; Ongoing Clinical Trials\n<\/p>\n<p>\n<strong>4 Synthetic Bone Graft Substitutes &#8211; Pipeline Products under Development by Companies<\/strong>\n<\/p>\n<p>\n4.1 Synthetic Bone Graft Substitutes Companies &#8211; Pipeline Products by Stage of Development\n<\/p>\n<p>\n4.2 Synthetic Bone Graft Substitutes &#8211; Pipeline Products by Stage of Development\n<\/p>\n<p>\n<strong>5 Synthetic Bone Graft Substitutes Companies and Product Overview<\/strong>\n<\/p>\n<p>\n5.1 Acuitive Technologies Inc Company Overview\n<\/p>\n<p>\n5.2 Agenta Biotechnologies Inc (Inactive) Company Overview\n<\/p>\n<p>\n5.3 Amend Surgical, Inc. Company Overview\n<\/p>\n<p>\n5.4 Anika Therapeutics Inc Company Overview\n<\/p>\n<p>\n5.5 Baxter International Inc Company Overview\n<\/p>\n<p>\n5.6 Berkeley Advanced Biomaterials Inc Company Overview\n<\/p>\n<p>\n5.7 Bio2 Technologies Inc Company Overview\n<\/p>\n<p>\n5.8 BioGend Therapeutics Co Ltd Company Overview\n<\/p>\n<p>\n5.9 Biomatlante SA Company Overview\n<\/p>\n<p>\n5.10 Biorez Inc Company Overview\n<\/p>\n<p>\n5.11 BonAlive Biomaterials Ltd. Company Overview\n<\/p>\n<p>\n5.12 Bone Solutions Inc Company Overview\n<\/p>\n<p>\n5.13 BoneGrafix, Inc. Company Overview\n<\/p>\n<p>\n5.14 BoneSupport AB Company Overview\n<\/p>\n<p>\n5.15 Calcitec, Inc. Company Overview\n<\/p>\n<p>\n5.16 Daewoong Pharmaceutical Co Ltd Company Overview\n<\/p>\n<p>\n5.17 Dimension Inx LLC Company Overview\n<\/p>\n<p>\n5.18 DSM Biomedical BV Company Overview\n<\/p>\n<p>\n5.19 Elute Inc Company Overview\n<\/p>\n<p>\n5.20 Eskisehir Osmangazi University Company Overview\n<\/p>\n<p>\n5.21 EternoGen Aesthetics LLC Company Overview\n<\/p>\n<p>\n5.22 Graftys SA Company Overview\n<\/p>\n<p>\n5.23 Industrie Biomediche Insubri SA Company Overview\n<\/p>\n<p>\n5.24 Innovoss Inc. (Inactive) Company Overview\n<\/p>\n<p>\n5.25 IRCCS San Raffaele Hospital Company Overview\n<\/p>\n<p>\n5.26 Isto Biologics Company Overview\n<\/p>\n<p>\n5.27 King&#8217;s College London Company Overview\n<\/p>\n<p>\n5.28 Maxigen Biotech Inc Company Overview\n<\/p>\n<p>\n5.29 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview\n<\/p>\n<p>\n5.30 National University of Science and Technology MiSiS Company Overview\n<\/p>\n<p>\n5.31 OrthoMedex LLC Company Overview\n<\/p>\n<p>\n5.32 PolyPid Ltd Company Overview\n<\/p>\n<p>\n5.33 Polytechnic University of Catalonia Company Overview\n<\/p>\n<p>\n5.34 Promimic AB Company Overview\n<\/p>\n<p>\n5.35 ReCaPP Company Overview\n<\/p>\n<p>\n5.36 RepRegen Ltd. (Inactive) Company Overview\n<\/p>\n<p>\n5.37 Revivicor Inc Company Overview\n<\/p>\n<p>\n5.38 Sanara MedTech Inc Company Overview\n<\/p>\n<p>\n5.39 Scil Technology GmbH Company Overview\n<\/p>\n<p>\n5.40 SDIP Innovations Pty Ltd Company Overview\n<\/p>\n<p>\n5.41 SIRAKOSS Ltd Company Overview\n<\/p>\n<p>\n5.42 Sofregen Medical Inc Company Overview\n<\/p>\n<p>\n5.43 Soteira Inc Company Overview\n<\/p>\n<p>\n5.44 Sree Chitra Tirunal Institute for Medical Sciences &amp; Technology Company Overview\n<\/p>\n<p>\n5.45 SurGenTec LLC Company Overview\n<\/p>\n<p>\n5.46 University of California San Diego Company Overview\n<\/p>\n<p>\n5.47 University of Edinburgh Company Overview\n<\/p>\n<p>\n5.48 Wright Medical Group NV Company Overview\n<\/p>\n<p>\n5.49 Xtant Medical Holdings Inc Company Overview\n<\/p>\n<p>\n<strong>6 Synthetic Bone Graft Substitutes- Recent Developments<\/strong>\n<\/p>\n<p>\n<strong>7 Appendix<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAcuitive Technologies Inc\n<\/li>\n<li>\nAgenta Biotechnologies Inc (Inactive)\n<\/li>\n<li>\nAmend Surgical, Inc.\n<\/li>\n<li>\nAnika Therapeutics Inc\n<\/li>\n<li>\nBaxter International Inc\n<\/li>\n<li>\nBerkeley Advanced Biomaterials Inc\n<\/li>\n<li>\nBio2 Technologies Inc\n<\/li>\n<li>\nBioGend Therapeutics Co Ltd\n<\/li>\n<li>\nBiomatlante SA\n<\/li>\n<li>\nBiorez Inc\n<\/li>\n<li>\nBonAlive Biomaterials Ltd.\n<\/li>\n<li>\nBone Solutions Inc\n<\/li>\n<li>\nBoneGrafix, Inc.\n<\/li>\n<li>\nBoneSupport AB\n<\/li>\n<li>\nCalcitec, Inc.\n<\/li>\n<li>\nDaewoong Pharmaceutical Co Ltd\n<\/li>\n<li>\nDimension Inx LLC\n<\/li>\n<li>\nDSM Biomedical BV\n<\/li>\n<li>\nElute Inc\n<\/li>\n<li>\nEskisehir Osmangazi University\n<\/li>\n<li>\nEternoGen Aesthetics LLC\n<\/li>\n<li>\nGraftys SA\n<\/li>\n<li>\nIndustrie Biomediche Insubri SA\n<\/li>\n<li>\nInnovoss Inc. (Inactive)\n<\/li>\n<li>\nIRCCS San Raffaele Hospital\n<\/li>\n<li>\nIsto Biologics\n<\/li>\n<li>\nKing&#8217;s College London\n<\/li>\n<li>\nMaxigen Biotech Inc\n<\/li>\n<li>\nNational Center of Innovation for Biomaterials in Orthopaedic Research\n<\/li>\n<li>\nNational University of Science and Technology MiSiS\n<\/li>\n<li>\nOrthoMedex LLC\n<\/li>\n<li>\nPolyPid Ltd\n<\/li>\n<li>\nPolytechnic University of Catalonia\n<\/li>\n<li>\nPromimic AB\n<\/li>\n<li>\nReCaPP\n<\/li>\n<li>\nRepRegen Ltd. (Inactive)\n<\/li>\n<li>\nRevivicor Inc\n<\/li>\n<li>\nSanara MedTech Inc\n<\/li>\n<li>\nScil Technology GmbH\n<\/li>\n<li>\nSDIP Innovations Pty Ltd\n<\/li>\n<li>\nSIRAKOSS Ltd\n<\/li>\n<li>\nSofregen Medical Inc\n<\/li>\n<li>\nSoteira Inc\n<\/li>\n<li>\nSree Chitra Tirunal Institute for Medical Sciences &amp; Technology\n<\/li>\n<li>\nSurGenTec LLC\n<\/li>\n<li>\nUniversity of California San Diego\n<\/li>\n<li>\nUniversity of Edinburgh\n<\/li>\n<li>\nWright Medical Group NV\n<\/li>\n<li>\nXtant Medical Holdings Inc\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5642711\/synthetic-bone-graft-substitutes-pipeline-report?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=75r28b&amp;utm_campaign=1790600+-+Global+Synthetic+Bone+Graft+Substitutes+Pipeline+Report+2022%3A+Featuring+BioGend+Therapeutics%2C+Biomatlante%2C+Biorez%2C+BonAlive+Biomaterials+and+Bone+Solutions+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/r1m45h<\/a>\n<\/p>\n<p>\nSource: GlobalData\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x70;&#114;&#101;&#115;&#115;&#64;&#114;&#101;sear&#x63;&#x68;&#x61;&#x6e;&#x64;&#x6d;&#x61;&#x72;&#x6b;&#101;&#116;&#115;&#46;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#x65;&#x73;s&#64;&#114;&#x65;&#x73;e&#97;&#114;&#x63;&#x68;a&#110;&#x64;&#x6d;&#x61;r&#107;&#x65;&#x74;s&#46;&#99;&#x6f;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Synthetic Bone Graft Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides comprehensive information about the Synthetic Bone Graft Substitutes pipeline products with comparative analysis of the products at various stages of development and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52046","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Synthetic Bone Graft Substitutes Pipeline Report 2022: Featuring BioGend Therapeutics, Biomatlante, Biorez, BonAlive Biomaterials and Bone Solutions Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Synthetic Bone Graft Substitutes Pipeline Report 2022: Featuring BioGend Therapeutics, Biomatlante, Biorez, BonAlive Biomaterials and Bone Solutions Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Synthetic Bone Graft Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides comprehensive information about the Synthetic Bone Graft Substitutes pipeline products with comparative analysis of the products at various stages of development and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-15T17:03:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221215005758\/en\/1666510\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Synthetic Bone Graft Substitutes Pipeline Report 2022: Featuring BioGend Therapeutics, Biomatlante, Biorez, BonAlive Biomaterials and Bone Solutions Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-12-15T17:03:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\\\/\"},\"wordCount\":862,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221215005758\\\/en\\\/1666510\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\\\/\",\"name\":\"Global Synthetic Bone Graft Substitutes Pipeline Report 2022: Featuring BioGend Therapeutics, Biomatlante, Biorez, BonAlive Biomaterials and Bone Solutions Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221215005758\\\/en\\\/1666510\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-12-15T17:03:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221215005758\\\/en\\\/1666510\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221215005758\\\/en\\\/1666510\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Synthetic Bone Graft Substitutes Pipeline Report 2022: Featuring BioGend Therapeutics, Biomatlante, Biorez, BonAlive Biomaterials and Bone Solutions Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Synthetic Bone Graft Substitutes Pipeline Report 2022: Featuring BioGend Therapeutics, Biomatlante, Biorez, BonAlive Biomaterials and Bone Solutions Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Synthetic Bone Graft Substitutes Pipeline Report 2022: Featuring BioGend Therapeutics, Biomatlante, Biorez, BonAlive Biomaterials and Bone Solutions Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Synthetic Bone Graft Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report provides comprehensive information about the Synthetic Bone Graft Substitutes pipeline products with comparative analysis of the products at various stages of development and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-15T17:03:08+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221215005758\/en\/1666510\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Synthetic Bone Graft Substitutes Pipeline Report 2022: Featuring BioGend Therapeutics, Biomatlante, Biorez, BonAlive Biomaterials and Bone Solutions Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-12-15T17:03:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/"},"wordCount":862,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221215005758\/en\/1666510\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/","name":"Global Synthetic Bone Graft Substitutes Pipeline Report 2022: Featuring BioGend Therapeutics, Biomatlante, Biorez, BonAlive Biomaterials and Bone Solutions Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221215005758\/en\/1666510\/21\/logo.jpg","datePublished":"2022-12-15T17:03:08+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221215005758\/en\/1666510\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221215005758\/en\/1666510\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-synthetic-bone-graft-substitutes-pipeline-report-2022-featuring-biogend-therapeutics-biomatlante-biorez-bonalive-biomaterials-and-bone-solutions-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Synthetic Bone Graft Substitutes Pipeline Report 2022: Featuring BioGend Therapeutics, Biomatlante, Biorez, BonAlive Biomaterials and Bone Solutions Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52046"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52046\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}